Resultados de procura - Robyn P.M. Saw

Limitar resultados
  1. 1
    Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

    Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma por Farhad Azimi, Richard A. Scolyer, Pavlina Rumcheva, Marc Moncrieff, Rajmohan Murali, Stanley W. McCarthy, Robyn P.M. Saw, John F. Thompson

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation

    Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation por Klaus J. Busam, Ricardo E. Vilain, Trina Lum, Jonathan A. Busam, Travis J. Hollmann, Robyn P.M. Saw, Daniel Coit, Richard A. Scolyer, Thomas Wiesner

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

    Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients por Hojabr Kakavand, Louise Jackett, Alexander M. Menzies, Tuba N. Gide, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma

    Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma por Matteo S. Carlino, Kavitha Gowrishankar, Catherine A.B. Saunders, Gulietta M. Pupo, Stephanie Snoyman, Xu Dong Zhang, Robyn P.M. Saw, Therese M. Becker, Richard Kefford, Georgina V. Long, Helen Rizos

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Diagnosis of Metastatic Melanoma by Fine-Needle Biopsy

    Diagnosis of Metastatic Melanoma by Fine-Needle Biopsy por Rajmohan Murali, Anna Doubrovsky, Geoffrey F. Watson, Paul McKenzie, C. Soon Lee, Duncan McLeod, Roger F. Uren, Jonathan R. Stretch, Robyn P.M. Saw, John F. Thompson, Richard A. Scolyer

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

    Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients por Tuba N. Gide, Inês Pires da Silva, Camelia Quek, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Marcel Batten, Georgina V. Long, Richard A. Scolyer, James S. Wilmott

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma

    The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma por Su Yin Lim, Elena Shklovskaya, Jenny Lee, Bernadette Pedersen, Ashleigh Stewart, Zizhen Ming, Mal Irvine, Brindha Shivalingam, Robyn P.M. Saw, Alexander M. Menzies, Matteo S. Carlino, Richard A. Scolyer, Georgina V. Long, Helen Rizos

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

    PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors por Hojabr Kakavand, Robert V. Rawson, Gulietta M. Pupo, Jean Yang, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Helen Rizos

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas

    Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas por Camelia Quek, Robert V. Rawson, Peter M. Ferguson, Ping Shang, Inês Pires da Silva, Robyn P.M. Saw, Kerwin F. Shannon, John F. Thompson, Nicholas K. Hayward, Georgina V. Long, Graham J. Mann, Richard A. Scolyer, James S. Wilmott

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

    Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients por Jenny Lee, Robyn P.M. Saw, John F. Thompson, Serigne Lo, Andrew J. Spillane, Kerwin F. Shannon, Jonathan R. Stretch, Julie R. Howle, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A. Scolyer, Helen Rizos

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

    Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma por Elena Shklovskaya, Jenny Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter M. Ferguson, Robyn P.M. Saw, John F. Thompson, Brindha Shivalingam, Matteo S. Carlino, Richard A. Scolyer, Alexander M. Menzies, Georgina V. Long, Richard Kefford, Helen Rizos

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center

    Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center por Alexander H. R. Varey, Chris Goumas, Angela Hong, Graham J. Mann, Gerald B. Fogarty, Jonathan R. Stretch, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Kenneth J. Lee, Michael J. Quinn, John F. Thompson, Richard A. Scolyer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma

    Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma por Georgina V. Long, Carina Fung, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Jessica Hyman, Hamideh Shahheydari, Varsha Tembe, John F. Thompson, Robyn P.M. Saw, Julie R. Howle, Nicholas K. Hayward, Peter A. Johansson, Richard A. Scolyer, Richard Kefford, Helen Rizos

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

    BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact por Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo, Matteo S. Carlino, Carina Fung, Jessica Hyman, Lauren E. Haydu, Branka Mijatov, Therese M. Becker, Suzanah C. Boyd, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, Richard Kefford, Richard A. Scolyer, Georgina V. Long

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

    Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition por Jenny Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Yang, Dario Strbenac, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard Kefford, Helen Rizos

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

    Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram por Serigne Lo, Jiawen Ma, Richard A. Scolyer, Lauren E. Haydu, Jonathan R. Stretch, Robyn P.M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Sydney Ch’ng, Graham J. Mann, Jeffrey E. Gershenwald, John F. Thompson, Alexander H. R. Varey

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

    Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma por Ricardo E. Vilain, Alexander M. Menzies, James S. Wilmott, Hojabr Kakavand, Jason Madore, Alexander Guminski, Elizabeth Liniker, Benjamin Y. Kong, Adam Cooper, Julie R. Howle, Robyn P.M. Saw, Valerie Jakrot, Serigne Lo, John F. Thompson, Matteo S. Carlino, Richard Kefford, Georgina V. Long, Richard A. Scolyer

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

    CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment por Jarem Edwards, James S. Wilmott, Jason Madore, Tuba N. Gide, Camelia Quek, Annie Tasker, Angela L. Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial

    Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial por T. S. Lee, Isabel Li, Barbara Perić, Robyn P.M. Saw, João Pedreira Duprat Neto, Eduardo Bertolli, John Spillane, Barbara L. van Leeuwen, Marc Moncrieff, Antonio Sommariva, Chris Allan, Johannes H.W. de Wilt, Rowan O. Pritchard Jones, Jenny L. C. Geh, Julie R. Howle, Andrew J. Spillane

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial

    Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial por Georgina V. Long, Matteo S. Carlino, George Au‐Yeung, Andrew J. Spillane, Kerwin F. Shannon, David Gyorki, Edward Hsiao, Rony Kapoor, Jake Thompson, Iris Batula, Julie R. Howle, Sydney Ch’ng, Maria Gonzalez, Robyn P.M. Saw, Thomas E. Pennington, Serigne Lo, Richard A. Scolyer, Alexander M. Menzies

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: